Home/Filings/4/0001415889-22-012991
4//SEC Filing

ALTSCHULLER Susan 4

Accession 0001415889-22-012991

CIK 0000855654other

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 5:14 PM ET

Size

8.0 KB

Accession

0001415889-22-012991

Insider Transaction Report

Form 4
Period: 2022-05-20
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-11-14+82,500123,750 total
    Exercise: $4.74From: 2022-11-14Exp: 2030-07-20Common Stock (82,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2022-05-20+41,25041,250 total
    Exercise: $4.74From: 2022-05-20Exp: 2030-07-20Common Stock (41,250 underlying)
Footnotes (2)
  • [F1]On July 20, 2020, the reporting person was granted an option to purchase 165,000 shares of common stock. The option vests in installments upon the satisfaction of certain performance criteria. On May 20, 2022, certain performance criteria were met, resulting in the vesting of 25% of the performance stock option award.
  • [F2]On July 20, 2020, the reporting person was granted an option to purchase 165,000 shares of common stock. The option vests in installments upon the satisfaction of certain performance criteria. On November 14, 2022, certain performance criteria were met, resulting in the vesting of 50% of the performance stock option award.

Issuer

ImmunoGen, Inc.

CIK 0000855654

Entity typeother

Related Parties

1
  • filerCIK 0001817988

Filing Metadata

Form type
4
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 5:14 PM ET
Size
8.0 KB